Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemia
β Scribed by Mills, A. K. ;Taylor, K. M. ;Wright, S. J. ;Bunce, I. ;Eliadis, P. ;Brigden, M. C. ;Seeley, G. ;Bashford, J. ;Olsen, T. ;Rentoul, A. ;Kelly, C.
- Book ID
- 109001117
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 645 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0004-8291
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The patient to be discussed today is an 8 1 β2-year-old girl. She was referred to us in February 1994 when 4 years old because of recurrent severe headaches, paraesthesias of the extremities, erythromelalgia, abdominal pain, and a platelet count of between 1,300 and 1,500 Γ 10 9 /L. Physical examina
## Abstract The objective of our study was to assess the efficacy and safety of donepezil in young adults with Down syndrome (DS) but no evidence of Alzheimer disease (AD). A 12βweek, randomized, doubleβblind, placeboβcontrolled study with a 12βweek, openβlabel extension was conducted. The interven